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Background: Studies have emphasized the importance of geographical factors and
general practitioner (GP) characteristics in influencing drug prescriptions.
Objectives: To: (i) ascertain the prevalence rate (PR) of use of drugs in six therapeutic
categories used for chronic conditions; (ii) assess how geographical characteristics and
GP characteristics may influence drug prescribing.
Methods: This study is part of the EDU.RE.DRUG Project, a national collaborative project
founded by Italian Medicine Agency (AIFA). Cross-sectional analyses were undertaken
employing the pharmacy-claim databases of four local health units (LHUs) located in two
Italian regions: Lombardy and Campania. Six drug categories were evaluated: proton-
pump inhibitors; antibiotics; respiratory-system drugs; statins; agents acting on the renin
−angiotensin system; psychoanaleptic drugs. The PR was estimated according to drug
categories at the LHU level. A linear multivariate regression analysis was undertaken to
evaluate the association between the PR and geographical area, age and sex of GPs,
number of patients, and percentage of patients aged >65 per GP.
Results: LHUs in Campania showed a PR that was significantly higher than that in
Lombardy. Antibiotics showed the highest PR in all the LHUs assessed, ranging from
32.5% in Lecco (Lombardy) to 59.7% in Naples-2 (Campania). Multivariate linear
regression analysis confirmed the association of the PR with geographical area for all
drug categories. Being located in Campania increased the possibility of receiving a drug
prescription from the categories considered, with estimates more marked for antibiotics,
proton-pump-inhibitors, and respiratory-system drugs.
Conclusions: This study provides information about the PR of medications used for
treating common and costly conditions in Italy and highlighted a significant geographical
variation. These insights could help to develop area-specific strategies to optimize
prescribing behavior.
Keywords: drug-utilization, geographical difference, prevalence, drug use, general practitioner, pharmacy claimsin.org May 2020 | Volume 11 | Article 4181
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Over the last century, advances in medical therapeutics have
contributed to improve global health and to increase life
expectancy. However, growing evidence suggests that
therapeutic decisions are often potentially inappropriate,
possibly resulting in negative outcomes, such as adverse drug
events, hospitalization, and increased healthcare resource
utilization (Arnold, 1999).
Appropriate prescription of medications is one of the most
important components of healthcare. It reflects the accuracy of
the diagnosis, adherence to evidence-based guidelines, and
susceptibility to drug-marketing and regulatory factors. It is
particularly challenging in older patients, mainly due to age-
related changes in pharmacokinetics and pharmacodynamics,
high numbers of concurrent medications, functional status, and
burden of co-morbid illness (Mort and Aparasu, 2002).
A lot of researches have tried to analyze and understand the
factors which influence physician prescribing decisions and
practice. Among the major determinants of drug prescription,
studies suggested the role of geographical differences. Scholars
have shown that drug use varies across regions in Europe and the
USA by more than would be expected based on population age
and health status alone (Couto et al., 2014; Nolte and Corbett,
2015). Such variations may be dependent upon differences in the
prescribing habits of general practitioners (GPs) and
socioeconomic status of patients (Odubanjo et al., 2004).
Furthermore, variations in prescription patterns among
different regions and between areas within the same region in
Italy have been documented (Russo et al., 2018; Orlando et al.,
2020). For instance, the Italian National Observatory on Drug
Prescription (OsMed) revealed that, in 2016, the overall
prescription for all reimbursed drugs, expressed in defined
daily doses (DDDs) per 1,000 inhabitants per day, was 900.7 in
northern Italy and 1,048.8 in southern Italy (Rapporto OsMed,
2018). Such geographical variations found further confirmation
in the work of Piovani et al. (Piovani et al., 2012) conducted in a
pediatric population, where a strong inverse correlation between
prescription patterns and latitude was observed.
Despite an increasing attention to variations in use of
prescribed drugs, little is known about the drivers of variations
in the prescribing patterns of GPs. Very few studies attempted to
quantify the geographical variation in drug prescriptions for
chronic conditions among adults and the elderly in Italian
regions (Orzella et al., 2010; Franchi et al., 2013).
Recently, the Italian Medicine Agency (AIFA) funded the
EDU.RE.DRUG Project (Effectiveness of informative and/or
educational interventions aimed at improving the appropriate
use of drugs designed for general practitioners and their
patients). The EDU.RE.DRUG Project aims to evaluate theAbbreviations: AIC, Marketing Authorization Code; AIFA, Italian Medicine
Agency; ATC, Anatomical Therapeutic Chemical classification; DDD, Defined
daily dose; GP, General practitioner; INHS, Italian National Health Service;
ISTAT, Italian Statistical Agency; LHU, Local health unit OsMed: Italian
National Observatory on Drug Prescription; OTC, Over-the-counter; PPI,
Proton pump inhibitor; PR, Prevalence rate; RSD, Respiratory-system drug.
Frontiers in Pharmacology | www.frontiersin.org 2appropriateness of drug prescription in people aged ≥40 years
living in Lombardy or Campania.
The present analysis is part of this national collaborative
project. We wished to: (i) describe the prescription pattern for
medications belonging to six therapeutic categories used for
chronic conditions; (ii) assess how geographical factors and GP
characteristics may influence prescription patterns.MATERIALS AND METHODS
Study Design
This was a retrospective drug-utilization study based on use
of administrative health-related databases. The study was
carried out according to the STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology)
guidelines (STROBE).
Study Setting and Population
Italian National Health Service (INHS) provides all citizens and
legal foreign residents with economic coverage of drugs with
documented clinical efficacy and which are used for treating
serious and chronic diseases. The amount of public money to be
spent on healthcare is established annually by the central
government. The money is assigned to regions to provide the
essential levels of care (LEA), which must be assured
homogenously to citizens throughout the country. Each region
allocates the funds to its local health units (LHUs) mainly on an
age-adjusted capitation basis. Assigned funds are used by LHUs
for the direct provision of inpatient and outpatient care, for GP
remuneration, and for the cost reimbursement of healthcare
services afforded by independent and university hospitals and/or
accredited private providers (Cicchetti and Gasbarrini, 2016).
The study was conducted in the primary care setting,
involving selected LHUs of two Italian regions: Lombardy and
Campania. Lombardy is one of the largest Italian regions,
situated in the north of the country, with a population of over
10,019,000 inhabitants. Campania is situated in the south of the
country and had a population of ~5,839,000 inhabitants on 1
January 2017 (Demo-Gedemo).
The LHUs involved in the study were: Naples-1 and Naples-2
in Campania, and Bergamo and Lecco in Lombardy, with an
overall population of ~3.4 million inhabitants. Patients aged ≥40
years, receiving at least one prescription of the study drugs, were
included in our study.
Sources and Collection of Data
The study data were obtained from administrative databases
containing information on all beneficiaries of INHS in the LHUs
involved. These databases are set-up and updated constantly by
regional or local health authorities. Demographic databases
contain anonymized data on residents (birth date and sex),
and on prescribers (GPs) (birth date and sex) of each LHU.
The pharmacy databases contain data on drug prescriptions
dispensed by local pharmacies and reimbursed by INHS,
including: patient's anonymous unique code; prescriber's (GP)May 2020 | Volume 11 | Article 418
Russo et al. Geographical Variation in Medication Prescriptionsanonymous unique code; prescription date; dispensation date;
Anatomical Therapeutic Chemical (ATC) classification;
marketing authorization code (AIC); number of DDDs;
number of boxes; cost for INHS (WHOCC).
Pharmacy databases were linked to demographic databases by
deterministic record-linkage procedures through the unique and
anonymous personal identification codes. Such codes were
created by a database manager, uninvolved in the data analysis,
in full preservation of individuals' privacy.
Drug-utilization data obtained from these databases have
been validated previously and used in drug-utilization studies
(Iolascon et al., 2013; Cammarota et al., 2014; Casula et al., 2014;
Iolascon et al., 2016; Putignano et al., 2017; Menditto
et al., 2018).
Drug Categories
We analyzed prescriptions of drugs belonging to six therapeutic
categories, pre-selected based on the higher prevalence in terms
of gross public expenditure and consumption.
The six therapeutic categories were: proton pump inhibitors
(PPIs) [A02BC]; antibiotics [J01]; respiratory-system drugs (RSDs)
[R03]; 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors
[C10AA]; agents acting on the renin–angiotensin system (C09,
including angiotensin-converting enzyme inhibitors [C09AA] and
angiotensin-II antagonists [C09CA]) and psychoanaleptic drugs
(N06, including selective serotonin reuptake inhibitors [N06AB]
and other antidepressants [N06AX]).
In Italy, drugs for the treatment of chronic conditions are
fully covered by INHS and, therefore, traceable through
administrative databases.
Study Outcomes
The year considered for this analysis was 2016. Medication use
for the identified therapeutic categories among adults (≥40 years)
was estimated as prevalence rate (PR), calculated for each GP asFrontiers in Pharmacology | www.frontiersin.org 3the proportion of patients who received at least one prescription
of the selected drugs per 100 GP patients of the same age range in
2016 The mean PR at the LHU level was adjusted by age using a
direct standardization method whereby the standard population
(also known as the “reference population”) was the Italian
population as extrapolated from Italian Statistical Agency
(ISTAT) data on 1 January 2017.
Statistical Analyses
Continuous variables (number of patients per GP and age of GP)
are expressed as median and interquartile-range deviation, as the
Shapiro-Wilk test showed that they did not have a normal
distribution. Categorical data are given as percentage.
PR at the LHU level was expressed as mean GP's PR and 95%
confidential interval. ANOVA was used to compare the
distributions of PRs by LHUs.
Amultivariate linear regression analysis was undertaken for each
selected therapeutic category. The PR was the dependent variable,
whereas the geographical area, number of patients per GP, age of
GP, sex of GP, and percentage of patients aged >65 years per GP
were inserted as independent variables.
Data management was undertaken with Microsoft SQL server
(version 2018). Statistical analyses were carried out with SPSS v17.1
(IBM, Armonk, NY, USA). P < 0.05 was considered significant.RESULTS
In 2016, for an overall population of 15,858,250 (5,839,084 in
Campania and 10,019,166 in Lombardy) GPs dispensed
31,584,437 prescriptions (22,331,915 prescriptions for Campania
and 9,252,522 prescriptions for Lombardy). Prescriptions for ATC-
selected categories (n = 11,609,123) accounted for 36.7% of the total
drugs prescribed. Figure 1 shows the regional databases available
and data selection employed.FIGURE 1 | Flowchart of data selection.May 2020 | Volume 11 | Article 418
Russo et al. Geographical Variation in Medication PrescriptionsTable 1 shows the main characteristics of GPs of the four
LHUs. The number of GPs ranged from 205 in Lecco to 777 in
Naples-2.
Most GPs were men (75.8%) and the median age was
~61 years.
The percentage of patients aged ≥65 years per GP was 21.0%,
with geographical variability (ranging from 15.0% for Naples-2
to 25.2% for Lecco; p < 0.001). A regional difference regarding
the median number of patients for each GP (~1500 in northern
Italy versus ~1300 in southern Italy) was noted.
PR at the LHU Level
Table 2 (and Supplementary Table S1) shows PR for each
selected drug category stratified by LHU (and for age class: 40–64
and >=65 years old). A significant difference in the PR among
LHUs was documented: in particular, LHUs located in the south
of Italy showed a higher PR compared with LHUs located in the
North of Italy for all drug categories (p < 0.001).
Among the drug categories evaluated, antibiotics showed the
higher PR, ranging from 32.5% in Lecco to 59.7% in Naples-2.
Psychoanaleptic drugs showed the lowest PRs, with the smallest
variations among LHUs (8.7% in Bergamo, 7.0% in Lecco, 8.3%Frontiers in Pharmacology | www.frontiersin.org 4Naples-1, and 8.6% Naples-2). PR for PPIs (A02BC) ranged from
21.9% in Lecco to 41.3% in Naples-2.
Multivariate Analyses
The regression model (Table 3 and Supplementary Tables S2
and S3) showed an association of the PR with geographical area
for all drug categories, with lower PRs in Northern Italy
compared to Southern Italy. The coefficients were notable for:
(i) antibiotics; (ii) PPIs; (iii) RSDs. Indeed, the average PR for
antibiotics was ~21% lower in northern Italy than in southern
Italy (B: −21.80; 95% confidence interval [CI]: −22.65 to −20.97;
p < 0.001). For PPIs, northern Italy showed a lower mean PR
compared with that in southern Italy (B: −17.33; 95% CI: −18.08
to −16.57; p < 0.001). Similar findings were observed for RSDs (B:
−10.76; 95% CI: −11.30 to −10.22; p < 0.001).
With regard to the number of patients per GP, we observed a
significant positive association for all selected drugs. Similar
results were observed with the percentage of patients aged >65
years per GP, with the exception of a negative association for
antibiotics (B: −0.37; 95% CI: −0.43; −0.31; p < 0.001) and RSDs
(B: −0.11; 95% CI: −0.15 to −0.07; p < 0.001). We also observed a
trend in decreasing PRs with increasing age of the GP.TABLE 2 | Prevalence rate of medication use by ATC group at the LHU level.
Northern Italy Southern Italy p*
Bergamo LHU Lecco LHU Naples-1 LHU Naples-2 LHU
Standardized
prevalence %
95% CI Standardized
prevalence %
95% CI Standardized
prevalence %
95% CI Standardized
prevalence %
95% CI
A02BC 24.1 (23.9; 24.2) 21.9 (21.7; 22.1) 40.0 (39.9; 40.2) 41.3 (41.1; 41.5) <0.001
C09 16.4 (16.3; 16.5) 19.8 (19.6; 20.0) 21.9 (21.8; 22.0) 22.2 (22.1; 22.4) <0.001
C10AA 15.3 (15.2; 15.4) 13.9 (13.7; 14.0) 19.3 (19.2; 19.4) 22.6 (22.4; 22.7) <0.001
J01 35.3 (35.1; 35.4) 32.5 (32.3; 32.8) 53.9 (53.7; 54.1) 59.7 (59.4; 59.9) <0.001
N06 8.7 (8.6; 8.8) 7.0 (6.9; 7.1) 8.3 (8.3; 8.4) 8.6 (8.5; 8.7) <0.001
R03 10.3 (10.2; 10.4) 9.4 (9.3; 9.6) 20.4 (20.2; 20.5) 21.8 (21.6; 21.9) <0.001May 2020 | Volume 11 | ArtA02BC: Proton pump inhibitors; C10AA: HMG CoA reductase inhibitors; J01: antibiotics; RO3: respiratory-system drugs;
C09: ACE inhibitors (C09AA) + angiotensin-II antagonists (C09CA); N06: selective serotonin reuptake inhibitors (N06AB) + another antidepressants (N06AX).
*ANOVA.TABLE 1 | GP characteristics at the LHU level.
Northern Italy Southern Italy Total LHUs
Bergamo LHU Lecco LHU Naples-1 LHU Naples-2 LHU (2, 956, 990 patients
aged ≥ 40 years)
(930, 124 patients aged
≥ 40 years)
(300, 215 patients aged
≥ 40 years)
(832, 780 patients aged
≥ 40 years)
(893, 871 patients aged
≥ 40 years)
GPs (N) 660 205 718 777 2,360
Patients per GP, median
(IQR)
1,519 (257) 1,553 (233) 1,267 (528) 1,305 (669) 1,401.50 (470)
Patients aged ≥ 65 years
per GP (%)
23.0 25.2 22.8 15.0 21.0
Age of GP, median (IQR) 59 (9) 60 (8) 62 (6) 60 (6) 61 (7)
Sex of GP
M (%) 67.1 71.2 78.7 81.9 75.8
F (%) 32.9 28.8 21.3 18.1 24.2icle 418
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Frontiers in Pharmacology | www.frontiersin.org 5The sex of GPs was significantly associated with the PR for drugs
based on the renin–angiotensin system (B: 0.44; 95% CI: 0.06 to
0.82; p = 0.022) and for antibiotic treatments (B: −0.96; 95% CI:
−1.77 to −0.14; p = 0.021): female GPs had a higher C09 mean PR
compared with male GPs, while low average of antibiotic PR.DISCUSSION
The prescribing of medicines is a complex process that goes on in
every healthcare setting, and whose principles are based on the
doctor's choice of the right drug for the right patient
(Abrahams, 2008).
Several studies suggested that some factors may have a role in
influencing the physicians' prescribing behavior. Such factors for
instance include, the age and sex of the physician or the patient,
or the socio-economic characteristics of the practicing area
(Bradley, 1992).
Inour study,wehighlighted that somecharacteristicsofGPs and
geography might affect the prescribing of drugs in terms of the PR.
In particular, a higher PR in southern Italy than in northern
Italy was observed. The greatest difference in the PR between
regions was observed for antibiotics, PPIs, and RSDs.
This finding is in accordance with observations from other
studies conducted in a similar setting (Piovani et al., 2012; Piovani
et al., 2014; Di Martino et al., 2017). Piovani et al. in 2012 showed a
mean antibiotic PR of 46.5% in the North of Italy, while Southern
Regions showed a mean PR of 61.1% (Piovani et al., 2012). This
geographical difference was observed again in a subsequent study
by the same authors, indicating that the PR of antibiotics and
RSDs in Southern Regions was higher (up to 57.5% and 27.0%,
respectively) than in the rest of Italy. The authors pointed out the
role of socioeconomic and sociodemographic factors in explaining
a higher PR in south Italy (Piovani et al., 2014). Furthermore,
studies analyzing the PR for antibiotics in Campania showed
results consistent with our data, and indicated that the PR was also
influenced by per capita income (Favato et al., 2007; Orzella et al.,
2010; Di Martino et al., 2017).
Notably, the selected drug categories include medications used
to treat common and costly conditions, and the observed
geographical differences may reflect differences in socio-
demographic indicators between the two Italian Regions. Indeed,
the differences observed between the two regions in terms of
prescription of drugs for chronic diseases may also be due to
differences in the socioeconomic context of the two regions.
According to a recent report from ISTAT, southern regions
have a lower income and socioeconomic level than those of
northern Italy. Indeed, the gross domestic product (GDP) is ~
€18,216 in Campania compared with ~€36,807 in Lombardy
Rapporto Oasi-Osservatorio sulle Aziende e sul Sistema sanitario
Italiano (2017). Supplementary Table S4 shows demographic and
socioeconomic characteristics by geographical area. The
Lombardy region, with 22.2% of patients aged ≥65 years, had an
older population than the Campania region (18.2%). Private
health expenditure per household showed quite high
geographical variability (ranging from €752 in the north to €303
in the south). Similar findings were observed for public-healthTA
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Russo et al. Geographical Variation in Medication Prescriptionsexpenditure per capita (ranging from €3,452.4 in Lombardy to
€1,479.6 in Campania). There is evidence that a lower income and
lower level of education are associated with greater use of health
services reimbursed by INHS (Grosso et al., 2012). Although we
have no data to confirm that hypothesis in our study, we can
assume that a higher GDP and higher level of education in
Lombardy can be associated with a lower PR of reimbursed
drugs for chronic conditions (Bianchi et al., 2011).
Furthermore, geographical differences in the prescribing
patterns between different areas of the same country may also
have several causes beyond socioeconomic differences. In Italy,
many health policies are designed and implemented at Regional
level. Among these, there may be indications orienting the
prescribing practice, essentially with the aim of cost
containment (for example, towards the choice of drugs with
comparable efficacy but lower costs) or of risk minimization (for
example, towards the choice of drugs associated with a better
tolerability profile of with less reporting of medication errors or
adverse events) (Russo et al., 2018; Orlando et al., 2020).
Other aspects of a GP's practice appear to have an impact on the
prevalence rates. In our study, a highnumber ofpatients perGPwas
associated with a greater likelihood of receiving prescriptions. This
relationship may be because a high number of listed patients may
imply a greater diversity of illnesses and, consequently, a greater
diversity of therapeutic needs (Tamblyn et al., 2003; Scala et al.,
2016). Moreover, GPs with a high percentage of people aged >65
years showed greater PRs. This finding, consistent with data from
other studies, could be explained by the higher number of
comorbidities usually affecting elderly patients (Tamblyn et al.,
2003). Interestingly, the stratification of the regression by Region
revealed that the positive association between older age of GP's
patients and PR was more marked in Lombardy than in Campania
(Supplementary Table S2 and S3).
Several associations found in our analysis were already been
observed by other researchers. Orzella et al. showed that younger
GPs were more likely to prescribe medications and suggested that
the number of years in practice could be a proxy of prescribing
behavior (Orzella et al., 2010). The sex of the GP did not seem to
have an influence on the PRs. However, consensus on the influence
of this factor on the prescribing attitude is lacking. Some studies
showed that female GPs are more likely to write prescriptions
(Morrison et al., 2009; Orzella et al., 2010), whereas in other studies
male GPs had higher rates of drug use than females (Tamblyn et al.,
2003; Haastrup et al., 2016).
Our study had two main limitations. First, pharmacy-claim
data do not contain information about over-the-counter (OTC)
medications and out-of-pocket expenditure, which could imply
underestimation. Second, a dispensed prescription does not
ensure that the medication was consumed by the patient. This,
in turn, implies that the PR may be an overestimate, as some
individuals filled out their prescriptions but did not take the
drug. Nevertheless, these two limitations are common in drug-
utilization studies carried out with administrative data.
Importantly, our study was not designed nor aimed to assess
the appropriateness of drug prescription. Therefore, the
quantification of use of the selected drug categories does notFrontiers in Pharmacology | www.frontiersin.org 6imply a qualitative judgment per se, as our data did not allow us
to evaluate if these prescriptions were appropriate. The purpose of
our analysis was to provide a picture of the PR for prescription of
major drug groups with respect to the geographical area in which
they were prescribed and the characteristics of prescribers. Further
research is required to achieve consistent assessment of the level of
potential prescribing inappropriateness among GPs. These actions
havebeenenvisagedas thenext steps in theEDU.RE.DRUGproject.
The present work represents the first step of this research project.
On the other hand, as a main strength of our study, we used a
population-based database, covering a defined and stable
population, which corresponded to ~26% of the Italian
population (Cicchetti and Gasbarrini, 2016). The age distribution
and sex distribution of the populationwas similar to the total Italian
population. Therefore, we believe that this study provides a reliable
representation of Italy, with an up-to-date overviewof drug use and
an evaluation of the relationship between geographical areas, GP
characteristics, and thePRofdrugprescription in a real-life context.
Although it is important to be aware of the limitations of
cross-sectional studies and their usefulness in the formulation of
future interventions (Illario et al., 2015; Illario et al., 2016), our
data could be very useful in planning interventions aimed at
improving the practice of drug prescribing. Successful elements
from activities in other countries should also be implemented.CONCLUSION
Geographical variations and GP characteristics are associated with
prescription of medications for treating common and costly
conditions in Italy. This study is the first step towards
the characterization of these differences, and future work is
needed to deepen and understand the reasons behind these
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